LONG-TERM PHOSPHODIESTERASE-5 INHIBITOR THERAPY PREVENTING PRIAPISM RECURRENCES

被引：0
|
作者：
Nardozza, Archimedes, Jr.
Coelho, Mariana Andrade
Oliveira, Frederico V.
Kobaz, Alberto K.
Alarcon, Gustavo
Offerni, Juliano C. M.
Cabrini, Marcelo R.
Ortiz, Valdemar
机构：
来源：
JOURNAL OF UROLOGY | 2009年 / 181卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(09)61492-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1478
引用
收藏
页码：528 / 529
页数：2
相关论文
共 50 条
  • [21] NEPHROPROTECTIVE EFFECTS OF CARNITINE AND PHOSPHODIESTERASE-5 INHIBITOR THERAPY IN CONTRAST-INDUCED NEPHROPATHY
    Armaly, Zaher A.
    Artul, Suheil
    Jabbour, Adel R.
    Farah, Raymond
    Elkadir, Amir Abd
    Abassi, Zaid
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 406 - 407
  • [22] Triple kinase inhibitor with phosphodiesterase-5 inhibitor for idiopathic pulmonary fibrosis
    Kishaba, Tomoo
    JOURNAL OF THORACIC DISEASE, 2018, 10 (11) : 5974 - 5978
  • [23] Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis
    Soulaidopoulos, Stergios
    Terentes-Printzios, Dimitrios
    Ioakeimidis, Nikolaos
    Tsioufis, Konstantinos P.
    Vlachopoulos, Charalambos
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (05) : 403 - 412
  • [24] Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine
    Jain, N
    Patil, CS
    Singh, A
    Kulkarni, SK
    PHARMACOLOGY, 2003, 67 (03) : 150 - 156
  • [25] The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size
    Sesti, C.
    Florio, V.
    Johnson, E. G.
    Kloner, R. A.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2007, 19 (01) : 55 - 61
  • [26] PULMONARY VASOREACTIVITY TESTING WITH ADENOSINE PREDICTS LONG TERM HEMODYNAMIC RESPONSE TO PROSTACYCLIN MONOTHERAPY, AND PROSTACYCLIN AND PHOSPHODIESTERASE-5 INHIBITOR COMBINATION THERAPY IN PULMONARY ARTERIAL HYPERTENSION
    Wehbe, Ramsey
    Rich, Jonathan
    Rich, Stuart
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1951 - 1951
  • [27] Daily Phosphodiesterase Type 5 Inhibitor Therapy as Rescue for Recurrent Ischemic Priapism After Failed
    Pierorazio, Phillip M.
    Bivalacqua, Trinity J.
    Burnett, Arthur L.
    JOURNAL OF ANDROLOGY, 2011, 32 (04): : 371 - 374
  • [28] A new oral phosphodiesterase-5 inhibitor Indicated for the treatment of ED
    不详
    FORMULARY, 2012, 47 (07) : 250 - 251
  • [29] Vardenafil: a selective inhibitor of phosphodiesterase-5 for the treatment of erectile dysfunction
    Reffelmann, Thorsten
    Kloner, Robert A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (07) : 965 - 974
  • [30] THE PREVALENCE OF PHOSPHODIESTERASE-5 INHIBITOR USAGE IN MEN WITH RETROGRADE EJACULATION
    Zhou, C.
    Mumtaz, M.
    Kulla, A.
    Wiseman, B.
    Campbell, K.
    JOURNAL OF SEXUAL MEDICINE, 2024, 21
12345